Peters Malte bought TNGX

January 8, 2026 · Form 4 insider transaction

Peters Malte bought 1,650,000 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,650,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after1,650,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This option shall vest and become exercisable over a four-year period, with 25% vesting on January 8, 2027 and the remaining option shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

View the original Form 4 on SEC EDGAR